| ［1］ |
Coles CE，Anderson BO，Cameron D，et al. The Lancet Breast Cancer Commission： tackling a global health，gender，and equity challenge［J］. Lancet，2022，399（10330）： 1101-1103.
|
| ［2］ |
Bray F，Laversanne M，Sung H，et al. Global cancer statistics 2022： GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries［J］. CA Cancer J Clin，2024，74（3）： 229-263.
|
| ［3］ |
Metcalfe KA，Finch A，Poll A，et al. Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation［J］. B J Cancer，2009，100（2）： 421-425.
|
| ［4］ |
Liu N，Yang DW，Wu YX，et al. Burden，trends，and risk factors for breast cancer in China from 1990 to 2019 and its predictions until 2034： an up-to-date overview and comparison with those in Japan and South Korea［J］. BMC Cancer，2022，22（1）： 826.
|
| ［5］ |
Giordano SB，Gradishar W. Breast cancer： updates and advances in 2016［J］. Curr Opin Obstet Gynecol，2017，29（1）： 12-17.
|
| ［6］ |
Dixon SJ，Lemberg KM，Lamprecht MR，et al. Ferroptosis： an iron-dependent form of nonapoptotic cell death［J］. Cell，2012，149（5）： 1060-1072.
|
| ［7］ |
Majno G，Joris I. Apoptosis，oncosis，and necrosis. An overview of cell death［J］. Am J Pathol，1995，146（1）： 3-15.
|
| ［8］ |
Stockwell BR，Jiang X，Gu W. Emerging mechanisms and disease relevance of ferroptosis［J］. Trends Cell Biol，2020，30（6）： 478-490.
|
| ［9］ |
Dixon SJ，Patel DN，Welsch M，et al. Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis［J］. Elife，2014，3： e02523.
|
| ［10］ |
Li C，Zhang Y，Liu J，et al. Mitochondrial DNA stress triggers autophagy-dependent ferroptotic death［J］. Autophagy，2021，17（4）： 948-960.
|
| ［11］ |
Sun S，Shen J，Jiang J，et al. Targeting ferroptosis opens new avenues for the development of novel therapeutics［J］. Signal Transduct Target Ther，2023，8（1）： 372.
|
| ［12］ |
Louandre C，Ezzoukhry Z，Godin C，et al. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib［J］. Int J Cancer，2013，133（7）： 1732-1742.
|
| ［13］ |
Guan C，Han Y，Ling Z，et al. Nanomaterials： breaking the bottleneck of breast cancer drug resistance［J］. Front Immunol，2024，15： 1492546.
|
| ［14］ |
He P，Lei Q，Yang B，et al. Dual-stage irradiation of size-switchable albumin nanocluster for cascaded tumor enhanced penetration and photothermal therapy［J］. ACS Nano，2022，16（9）： 13919-13932.
|
| ［15］ |
Deng W，Shang H，Tong Y，et al. The application of nanoparticles-based ferroptosis，pyroptosis and autophagy in cancer immunotherapy［J］. J Nanobiotechnology，2024，22（1）： 97.
|
| ［16］ |
Shen Y，Li X，Dong D，et al. Transferrin receptor 1 in cancer： a new sight for cancer therapy［J］. Am J Cancer Res，2018，8（6）： 916-931.
|
| ［17］ |
Zhang Y，Zou L，Li X，et al. SLC40A1 in iron metabolism，ferroptosis，and disease： a review［J］. WIREs Mech Dis，2024，16（4）： e1644.
|
| ［18］ |
Jiang L，Wang J，Wang K，et al. RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation［J］. Blood，2021，138（8）： 689-705.
|
| ［19］ |
Mansuer M，Zhou L，Wang C，et al. Erianin induces ferroptosis in GSCs via REST/LRSAM1 mediated SLC40A1 ubiquitination to overcome TMZ resistance［J］. Cell Death Dis，2024，15（7）： 522.
|
| ［20］ |
He XY，Fan X，Qu L，et al. LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism［J］. Nat Commun，2023，14（1）： 2253.
|
| ［21］ |
Luo C，Liang H，Ji M，et al. Autophagy induced by mechanical stress sensitizes cells to ferroptosis by NCOA4-FTH1 axis［J］. Autophagy，2025，21（6）： 1263-1282.
|
| ［22］ |
Wang M，Zhang W，Liu B，et al. Boosting cancer cell ferroptosis with carbon monoxide poisoned hemoglobin［J］. J Am Chem Soc，2025，147（20）： 17372-17383.
|
| ［23］ |
Lu YS，Gu FF，Ma YW，et al. Tumor cell membrane-camouflaged vortex magnetic nanoannulars programmed by low-frequency magnetic field： a novel anti-cancer delivery system in triple-negative breast cancer［J］. Adv Funct Mater，2024，34（42）：2401940.
|
| ［24］ |
Zuo T，Fang T，Zhang J，et al. pH-sensitive molecular-switch-containing polymer nanoparticle for breast cancer therapy with ferritinophagy-cascade ferroptosis and tumor immune activation［J］. Adv Healthc Mater，2021，10（21）： e2100683.
|
| ［25］ |
Liu Y，Sun Q，Guo J，et al. Dual ferroptosis induction in N2-TANs and TNBC cells via FTH1 targeting： a therapeutic strategy for triple-negative breast cancer［J］. Cell Rep Med，2025，6（1）： 101915.
|
| ［26］ |
Dixon SJ，Stockwell BR. The role of iron and reactive oxygen species in cell death［J］. Nat Chem Biol，2014，10（1）： 9-17.
|
| ［27］ |
Jiang X，Stockwell BR，Conrad M. Ferroptosis： mechanisms，biology and role in disease［J］. Nat Rev Mol Cell Biol，2021，22（4）： 266-282.
|
| ［28］ |
Jia B，Li J，Song Y，et al. ACSL4-mediated ferroptosis and its potential role in central nervous system diseases and injuries［J］. Int J Mol Sci，2023，24（12）：10021.
|
| ［29］ |
Zhao Y，Linkermann A，Takahashi M，et al. Ferroptosis in cardiovascular disease： regulatory mechanisms and therapeutic implications［J］. Eur Heart J，2025, 46(33):3247-3260.
|
| ［30］ |
Zhang J，Van Der Wouden PE，Dekker FJ. Novel 15-lipoxygenase-1 inhibitor protects cells from RSL3-induced cell death［J］. Eur J Med Chem，2025，290： 117517.
|
| ［31］ |
Doll S，Proneth B，Tyurina YY，et al. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition［J］. Nat Chem Biol，2017，13（1）： 91-98.
|
| ［32］ |
Ye L，Wen X，Qin J，et al. Metabolism-regulated ferroptosis in cancer progression and therapy［J］. Cell Death Dis，2024，15（3）： 196.
|
| ［33］ |
Yang F，Xiao Y，Ding JH，et al. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy［J］. Cell Metab，2023，35（1）： 84-100.
|
| ［34］ |
Pizzino G，Irrera N，Cucinotta M，et al. Oxidative stress： harms and benefits for human health［J］. Oxid Med Cell Longev，2017，2017： 8416763.
|
| ［35］ |
Patel SA，Warren BA，Rhoderick JF，et al. Differentiation of substrate and non-substrate inhibitors of transport system xc(-)： an obligate exchanger of L-glutamate and L-cystine［J］. Neuropharmacology，2004，46（2）： 273-284.
|
| ［36］ |
Bridges R，Lutgen V，Lobner D，et al. Thinking outside the cleft to understand synaptic activity： contribution of the cystine-glutamate antiporter （System xc-） to normal and pathological glutamatergic signaling［J］. Pharmacol Rev，2012，64（3）： 780-802.
|
| ［37］ |
Xue X，Wang M，Cui J，et al. Glutathione metabolism in ferroptosis and cancer therapy［J］. Cancer Lett，2025，621： 217697.
|
| ［38］ |
Xiang S，Yan W，Ren X，et al. Role of ferroptosis and ferroptosis-related long non'coding RNA in breast cancer［J］. Cell Mol Biol Lett，2024，29（1）： 40.
|
| ［39］ |
Dai C，Chen X，Li J，et al. Transcription factors in ferroptotic cell death［J］. Cancer Gene Ther，2020，27（9）： 645-656.
|
| ［40］ |
Chen X，Kang R，Kroemer G，et al. Broadening horizons： the role of ferroptosis in cancer［J］. Nat Rev Clin Oncol，2021，18（5）： 280-296.
|
| ［41］ |
Wang L，Liu Y，Du T，et al. ATF3 promotes erastin-induced ferroptosis by suppressing system Xc（）［J］. Cell Death Differ，2020，27（2）： 662-675.
|
| ［42］ |
Wang W，Green M，Choi JE，et al. CD8（+） T cells regulate tumour ferroptosis during cancer immunotherapy［J］. Nature，2019，569（7755）： 270-274.
|
| ［43］ |
Costa I，Barbosa DJ，Benfeito S，et al. Molecular mechanisms of ferroptosis and their involvement in brain diseases［J］. Pharmacol Ther，2023，244： 108373.
|
| ［44］ |
Wang M，Chen Q，Cheng ZY，et al. A responsive hydrogel containing bimetallic mof enabling amplified ferroptosis for cancer therapy via dual cellular homeostasis disruption［J］. Adv Funct Mater，2025： e02635.
|
| ［45］ |
Kandasamy G，Maity D. Recent advances in superparamagnetic iron oxide nanoparticles （SPIONs） for in vitro and in vivo cancer nanotheranostics［J］. Int J Pharm，2015，496（2）： 191-218.
|
| ［46］ |
Mahmoudi M，Sant S，Wang B，et al. Superparamagnetic iron oxide nanoparticles （SPIONs）： development，surface modification and applications in chemotherapy［J］. Adv Drug Deliv Rev，2011，63（1-2）： 24-46.
|
| ［47］ |
Samari M，Alamzadeh Z，Irajirad R，et al. FROP-1 peptide-conjugated ultrasmall superparamagnetic nanoparticles as a targeted T1-weighted MR contrast agent for breast cancer： in vitro study［J］. BMC Biomed Eng，2025，7（1）： 5.
|
| ［48］ |
Pham TM，Cao DV，Dang HHQ，et al. （153）Sm-labeled Fe（3）O（4）@lapatinib nanoparticles as a potential therapeutic agent for breast cancer： synthesis，quality control，and in vivo evaluation［J］. J Mater Chem B，2024，12（3）： 678-690.
|
| ［49］ |
Lu YS，Gu FF，Ma YW，et al. Tumor cell membrane-camouflaged vortex magnetic nanoannulars programmed by low-frequency magnetic field： a novel anti-cancer delivery system in triple-negative breast cancer［J］. Adv Funct Mater，2024，34（42）： 16.
|
| ［50］ |
Zhang F，Li F，Lu GH，et al. Engineering magnetosomes for ferroptosis/immunomodulation synergism in cancer［J］. ACS Nano，2019，13（5）： 5662-5673.
|
| ［51］ |
Wu GL，Tan S，Tan X，et al. Recent advances in ferrocene-based nanomedicines for enhanced chemodynamic therapy［J］. Theranostics，2025，15（2）： 384-407.
|
| ［52］ |
Hu Y，Fang Z，Yao B，et al. Ferrocene derivatives for photothermal applications［J］. ChemSusChem，2024，17（23）： e202400829.
|
| ［53］ |
Yang X，Feng C，Wang P，et al. Precisely self-cooperative nanoassembly enables photothermal/ferroptosis synergistic tumor eradication［J］. Adv Healthc Mater，2024，13（18）： e2304485.
|
| ［54］ |
Zhang J，Yang J，Zuo T，et al. Heparanase-driven sequential released nanoparticles for ferroptosis and tumor microenvironment modulations synergism in breast cancer therapy［J］. Biomaterials，2021，266： 120429.
|
| ［55］ |
Yang N，Pan X，Zhou X，et al. Biomimetic nanoarchitectonics with chitosan nanogels for collaborative induction of ferroptosis and anticancer immunity for cancer therapy［J］. Adv Healthc Mater，2024，13（7）： e2302752.
|
| ［56］ |
Xu J，Tan J，Song C，et al. Self-immolative amphiphilic poly（ferrocenes） for synergistic amplification of oxidative stress in tumor therapy［J］. Angew Chem Int Ed Engl，2023，62（30）： e202303829.
|
| ［57］ |
Chai W，Chen X，Liu J，et al. Recent progress in functional metal-organic frameworks for bio-medical application［J］. Regen Biomater，2024，11： rbad115.
|
| ［58］ |
Sun Y，Zheng L，Yang Y，et al. Metal-organic framework nanocarriers for drug delivery in biomedical applications［J］. Nanomicro Lett，2020，12（1）： 103.
|
| ［59］ |
Tang Z，Liu Y，He M，et al. Chemodynamic therapy： tumour microenvironment-mediated fenton and fenton-like reactions［J］. Angew Chem Int Ed Engl，2019，58（4）： 946-956.
|
| ［60］ |
Cao C，Lu Y，Pan X，et al. Time and space dual-blockade strategy for highly invasive nature of triple-negative breast cancer in enhanced sonodynamic therapy based on Fe-MOF nanoplatforms［J］. Adv Healthc Mater，2024，13（15）： e2304249.
|
| ［61］ |
Li K，Lin C，Li M，et al. Multienzyme-like reactivity cooperatively impairs glutathione peroxidase 4 and ferroptosis suppressor protein 1 pathways in triple-negative breast cancer for sensitized ferroptosis therapy［J］. ACS Nano，2022，16（2）： 2381-2398.
|
| ［62］ |
Khalid S，Ahmed E，Khan Y，et al. Nanocrystalline pyrite for photovoltaic applications［J］. Chemistryselect，2018，3（23）： 6488-6524.
|
| ［63］ |
Zhao C，Liu Z，Chang CC，et al. Near-infrared phototheranostic iron pyrite nanocrystals simultaneously induce dual cell death pathways via enhanced fenton reactions in triple-negative breast cancer［J］. ACS Nano，2023，17（5）： 4261-4278.
|
| ［64］ |
Yuan Y，Wang L，Gao L. Nano-sized iron sulfide： structure，synthesis，properties，and biomedical applications［J］. Front Chem，2020，8： 818.
|
| ［65］ |
Wang C，Liu Q，Huang X，et al. Ferritin nanocages： a versatile platform for nanozyme design［J］. J Mater Chem B，2023，11（19）： 4153-4170.
|
| ［66］ |
Mohanty A，Parida A，Raut RK，et al. Ferritin： a promising nanoreactor and nanocarrier for bionanotechnology［J］. ACS Bio Med Chem Au，2022，2（3）： 258-281.
|
| ［67］ |
Fan X，Zhang X，Liu LC，et al. Hemopexin accumulates in kidneys and worsens acute kidney injury by causing hemoglobin deposition and exacerbation of iron toxicity in proximal tubules［J］. Kidney Int，2022，102（6）： 1320-1330.
|
| ［68］ |
Bussin B，Macduff MGG，Ngo W，et al. Discovering nanoparticle corona ligands for liver macrophage capture［J］. Nat Nanotechnol，2025，20（7）： 914-925.
|
| ［69］ |
Li YL，Zheng XD，Chu Q. Bio-based nanomaterials for cancer therapy［J］. Nano Today，2021，38： 25.
|
| ［70］ |
Huang P，Wang C，Deng H，et al. Surface Engineering of Nanoparticles toward Cancer Theranostics［J］. Acc Chem Res，2023，56（13）： 1766-1779.
|
| ［71］ |
Sabit H，Pawlik TM，Radwan F，et al. Precision nanomedicine： navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery［J］. Mol Cancer，2025，24（1）： 160.
|
| ［72］ |
Ma P，Luo Q，Chen J，et al. Intraperitoneal injection of magnetic Fe3O4-nanoparticle induces hepatic and renal tissue injury via oxidative stress in mice［J］. Int J Nanomedicine，2012，7： 4809-4818.
|
| ［73］ |
Zhang Q，Yan S，Yan X，et al. Recent advances in metal-organic frameworks： Synthesis，application and toxicity［J］. Sci Total Environ，2023，902： 165944.
|